James Van Der Beek Raised Awareness of Colorectal Cancer Warning Signs Months Before Death

Actor James Van Der Beek’s Subtle Colon Cancer Warning Sign Highlights Screening Importance

The entertainment world continues to mourn the loss of “Dawson’s Creek” star James Van Der Beek, who passed away at age 48 from colorectal cancer. His wife, Kimberly Van Der Beek, confirmed his death on social media Wednesday, just months after the actor revealed his cancer diagnosis in November 2024.

What’s particularly striking about Van Der Beek’s case was the subtlety of his symptoms. In an August interview with Healthline, the actor shared that “there wasn’t any red flag or something glaring” that would have signaled the presence of stage 3 cancer.

“I was healthy. I was doing the cold plunge,” Van Der Beek said. “I was in amazing cardiovascular shape, and I had stage 3 cancer, and I had no idea.”

The actor noted that his only symptom was a change in bowel movements, which he initially attributed to his coffee consumption. This seemingly minor change turned out to be the only warning sign of his serious condition.

Van Der Beek also admitted his lack of awareness about current screening recommendations. “Before my diagnosis, I didn’t know much about colorectal cancer,” he said. “I didn’t even realize the screening age had dropped to 45; I thought it was still 50.”

Medical experts confirm that subtle changes in bowel habits are often the first indication of colorectal cancer. Professor Eitan Friedman, an oncologist and founder of The Suzanne Levy-Gertner Oncogenetics Unit at the Sheba Medical Center in Israel, identified additional warning signs including fatigue linked to anemia, blood in stool, weight loss, loss of appetite, and abdominal discomfort.

Dr. Erica Barnell, a physician-scientist at Washington University School of Medicine and co-founder of Geneoscopy, emphasized that Van Der Beek’s experience is not uncommon. “Many colorectal cancers develop silently, without obvious symptoms,” she explained. “By the time symptoms appear, the disease may already be advanced.”

These warning signs become particularly concerning for individuals 45 and older, especially those with a family history of colon cancer or other gastrointestinal malignancies, and people with inflammatory bowel diseases like ulcerative colitis or Crohn’s disease.

The average lifetime risk of developing colorectal cancer for a person with no special risk factors is 4% to 5%, according to Dr. Friedman. However, this risk can be significantly reduced through regular screening. Colonoscopy beginning at age 45, performed at five- to ten-year intervals, has proven effective in detecting potentially malignant polyps early and allowing for their removal before they become cancerous.

Despite the clear benefits of screening, compliance rates in the United States remain below national targets. Dr. Barnell noted that screening gaps are widest in rural, low-income, and minority communities. To address this issue, she advocates for greater access to “accurate, noninvasive screening technologies” and increased public awareness efforts.

“Most people don’t like talking about bowel habits, but paying attention to changes can save your life,” Dr. Barnell emphasized. “Screening gives us the chance to find problems early — often before you feel sick — and that can make all the difference.”

Van Der Beek’s tragic case serves as a powerful reminder of the importance of routine colorectal cancer screening beginning at age 45, as well as the need to be attentive to even subtle changes in bowel habits. His openness about his diagnosis and symptoms before his death may help raise awareness and potentially save lives through early detection.

Colorectal cancer has become increasingly prevalent among younger adults in recent years, prompting health organizations to lower the recommended screening age from 50 to 45 for people at average risk. For those with family history or other risk factors, screening may need to begin even earlier.